Works matching Bristol-Myers Squibb Company

Results: 1093
    1

    Morphology Zosteriform skin metastases.

    Published in:
    International Journal of Dermatology, 2004, v. 43, n. 2, p. 126, doi. 10.1111/j.1365-4632.2004.02112.x
    By:
    • LeSueur, Benjamin W.;
    • Abraham, Ryan J.;
    • DiCaudo, David J.;
    • O'Connor, William F.
    Publication type:
    Article
    2
    3
    4

    129-LB: Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex in the CREDENCE Trial.

    Published in:
    Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-129-LB
    By:
    • YI, TAE WON;
    • SMYTH, BRENDAN;
    • KANG, AMY;
    • CARDOZA, KATHRYN;
    • TANNA, GIAN LUCA DI;
    • ARNOTT, CLARE;
    • POLLOCK, CAROL A.;
    • AGARWAL, RAJIV;
    • BAKRIS, GEORGE;
    • CANNON, CHRISTOPHER P.;
    • DE ZEEUW, DICK;
    • HEERSPINK, HIDDO L.;
    • LEVIN, ADEERA;
    • NEAL, BRUCE;
    • WHEELER, DAVID C.;
    • ZHANG, HONG;
    • ZINMAN, BERNARD;
    • MAHAFFEY, KENNETH W.;
    • PERKOVIC, VLADO;
    • JARDINE, MEG J.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12

    17-OR: Efficacy and Safety of Chiglitazar, a Novel PPARα/γ/d Pan-Agonist, in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial (CMAP).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-17-OR
    By:
    • JI, LINONG;
    • SONG, WEIHONG;
    • FANG, HUI;
    • LI, WEI;
    • GENG, JIANLIN;
    • XU, YAN CHENG;
    • WANG, YANGANG;
    • GUO, LIAN;
    • CAI, HANQING;
    • YANG, TAO;
    • LI, HONG-MEI;
    • YANG, GANGYI;
    • LI SR., QIFU;
    • LIU, KUANZHI;
    • LI, SHUYING;
    • LIU, YANJUN;
    • SHI, FUYAN;
    • LI, XIN SHENG;
    • GAO, XIN;
    • JI, QIUHE
    Publication type:
    Article
    13
    14
    15
    16

    1448-P: Potential Overtreatment of Older Patients with T2D: The Global DISCOVER Study.

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1448-P
    By:
    • BONGAERTS, BRENDA;
    • ARNOLD, SUZANNE V.;
    • CHARBONNEL, BERNARD;
    • CHEN, HUNGTA;
    • CID-RUZAFA, JAVIER;
    • FENICI, PETER;
    • GOMES, MARILIA B.;
    • JI, LINONG;
    • KHUNTI, KAMLESH;
    • KOSIBOROD, MIKHAIL N.;
    • SARAIVA, GABRIELA LUPORINI;
    • MEDINA, JESUS;
    • NICOLUCCI, ANTONIO;
    • POCOCK, STUART;
    • SADIKOT, SHAUKAT M.;
    • SHESTAKOVA, MARINA V.;
    • SHIMOMURA, IICHIRO;
    • SURMONT, FILIP;
    • TANG, FENGMING;
    • WATADA, HIROTAKA
    Publication type:
    Article
    17
    18
    19
    20

    8-OR: Use of Guideline-Recommended Risk-Reduction Strategies among Patients with Type 2 Diabetes and Established ASCVD: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-8-OR
    By:
    • KOSIBOROD, MIKHAIL N.;
    • LEMOS, JAMES DE;
    • ROSENSON, ROBERT S.;
    • BALLANTYNE, CHRISTIE M.;
    • PHILIP, KIRAN;
    • LIU, YUYIN;
    • MUES, KATHERINE E.;
    • ALAM, SHUSHAMA;
    • ELLIOTT, MARY;
    • BHATT, DEEPAK L.;
    • CANNON, CHRISTOPHER P.
    Publication type:
    Article
    21
    22
    23
    24

    432-P: Analyses of First plus Recurrent Cardiovascular and Hospitalization Events in the Cardiovascular and Renal Microvascular Outcome Study with Linagliptin (CARMELINA) in Patients with Type 2 Diabetes and Cardiorenal Disease.

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-432-P
    By:
    • MARX, NIKOLAUS;
    • MCGUIRE, DARREN K.;
    • JOHANSEN, ODD ERIK;
    • ROSENSTOCK, JULIO;
    • KAHN, STEVEN E.;
    • COOPER, MARK E.;
    • TOTO, ROBERT D.;
    • WANNER, CHRISTOPH;
    • PFARR, EGON;
    • SCHNAIDT, SVEN;
    • GEORGE, JYOTHIS;
    • EYNATTEN, MAXIMILIAN VON;
    • PERKOVIC, VLADO;
    • ZINMAN, BERNARD;
    • ALEXANDER, JOHN H.
    Publication type:
    Article
    25
    26
    27
    28

    1148-P: Cenicriviroc Safety in over 1,200 Subjects.

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1148-P
    By:
    • ABDELMALEK, MANAL F.;
    • CHARLTON III, RALPH W.;
    • MARTINS, EDUARDO B.;
    • TAN, BILL;
    • COVIELLO, ANDREA D.;
    • ALKHOURI, NAIM
    Publication type:
    Article
    29
    30

    244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial.

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-244-OR
    By:
    • RAZ, ITAMAR;
    • WIVIOTT, STEPHEN D.;
    • YANUV, ILAN;
    • ROZENBERG, ALIZA;
    • ZELNIKER, THOMAS A.;
    • CAHN, AVIVIT;
    • HEERSPINK, HIDDO L.;
    • DWYER, JAMIE P.;
    • GOODRICH, ERICA;
    • BHATT, DEEPAK L.;
    • LEITER, LAWRENCE A.;
    • MCGUIRE, DARREN K.;
    • WILDING, JOHN P.;
    • GAUSE-NILSSON, INGRID ANNA;
    • FREDRIKSSON, MARTIN;
    • JOHANSSON, PETER A.;
    • LANGKILDE, ANNA MARIA;
    • SABATINE, MARC S.;
    • MOSENZON, OFRI
    Publication type:
    Article
    31
    32
    33
    34

    207-LB: Type 2 Diabetes and Heart Failure: Insights from the DISCOVER Study.

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-207-LB
    By:
    • ARNOLD, SUZANNE V.;
    • CHEN, HUNGTA;
    • CID-RUZAFA, JAVIER;
    • FENICI, PETER;
    • GOMES, MARILIA B.;
    • KHUNTI, KAMLESH;
    • LUPORINI SARAIVA, GABRIELA;
    • MEDINA, JESUS;
    • POCOCK, STUART;
    • SADIKOT, SHAUKAT M.;
    • SHESTAKOVA, MARINA V.;
    • SHIMOMURA, IICHIRO;
    • SURMONT, FILIP;
    • TANG, FENGMING;
    • VORA, JITEN;
    • WATADA, HIROTAKA;
    • JI, LINONG;
    • CHARBONNEL, BERNARD;
    • BONNET, FABRICE;
    • KOSIBOROD, MIKHAIL N.
    Publication type:
    Article
    35
    36
    37

    18-OR: Efficacy and Safety of Chiglitazar vs. Sitagliptin in Patients with Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Noninferiority Phase 3 Trial (CMAS).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-18-OR
    By:
    • JIA, WEIPING;
    • MA, JIANHUA;
    • MIAO, HENG;
    • WANG, CHANGJIANG;
    • WANG, XIAOYUE;
    • LI, QUANMIN;
    • LU, WEIPING;
    • YANG, JIALIN;
    • ZHANG, LIHUI;
    • YANG, JINKUI;
    • WANG, GUIXIA;
    • ZHANG, XIUZHENG;
    • ZHANG, MIN;
    • SUN, LI;
    • YU, XUEFENG;
    • DU, JIANLING;
    • SHI, BINGYIN;
    • XIAO, CHANGQING;
    • ZHU, DALONG;
    • LIU, HONG
    Publication type:
    Article
    38

    1876-P: Impact of Diabetes on Liver Disease Progression in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1876-P
    By:
    • SANYAL, ARUN J.;
    • ABDELMALEK, MANAL F.;
    • CALDWELL, STEPHEN;
    • SHIFFMAN, MITCHELL L.;
    • GHALIB, REEM;
    • LAWITZ, ERIC;
    • JIANG, DEYUAN;
    • AGUILAR SCHALL, RAUL E.;
    • MCCOLGAN, BRYAN J.;
    • MYERS, ROB;
    • DJEDJOS, STEPHEN;
    • MUIR, ANDREW;
    • RATZIU, VLAD;
    • AFDHAL, NEZAM;
    • GOODMAN, ZACHARY;
    • BOSCH, JAIME;
    • HARRISON, STEPHEN A.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke<sup>®</sup> and Glucophage<sup>®</sup>-XR) in healthy Chinese volunteers: a randomized phase I clinical trial.

    Published in:
    Annals of Medicine, 2022, v. 54, n. 1, p. 2626, doi. 10.1080/07853890.2022.2125574
    By:
    • Sun, Ming-Li;
    • Liu, Chen;
    • Bai, Hai-Hong;
    • Wei, Ya-Li;
    • Zhang, Wei;
    • Liu, Hui-Juan;
    • Li, Yin-Juan;
    • Liu, Long;
    • Wang, Yu;
    • Tong, Yuan-Xv;
    • Gao, Qian;
    • Liu, Qian-Ying;
    • Wang, Xinghe
    Publication type:
    Article
    45
    46

    Untitled.

    Published in:
    JAMA: Journal of the American Medical Association, 1993, v. 270, n. 7, p. 805
    Publication type:
    Article
    47
    48
    49
    50